Dr. Levine is a Buffalo Spree Top Doctor! See all of our physicians who made this year's list.
Cancers Treated:
Specializing In:
Bladder Cancer Breast Cancer Prostate Cancer Testicular CancerSpecial Interests:
Novel therapies for breast and urothelial cancerAbout Ellis Levine
Positions
Roswell Park Comprehensive Cancer Center
- Professor of Oncology
- Chief, Breast Medicine
- Hematology/Medical Oncology Fellowship Director
- Department of Medicine
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
- Professor of Medicine
- Director, Hematology/Medical Oncology Fellowship Program
Background
Education and Training:
- MD - University of Pittsburgh, Pittsburgh, PA
Residency:
- University of Minnesota, Minneapolis, MN
Fellowship:
- University of Minnesota, Minneapolis, MN
Board Certification:
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
Honors & Awards:
- 2005-2018 - America’s Top Doctors
- 2018 - Susan G. Komen Hope Award for Upstate New York
Clinical Trials
Featured on Cancer Talk
Showing all3 of 9 CollapseView all
Publications
Eastham JA, Heller G, Hillman DW, Hahn OM, Parsons JK, Mohler JL, Small EJ, Morris M. Baseline Testosterone Levels in Men with Clinically Localized High-Risk Prostate Cancer Treated with Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy (Alliance). J Urol. 2021 Aug;206(2):319-324. doi: 10.1097/JU.0000000000001716. Epub 2021 Mar 29. PubMed PMID: 33780276; PubMed Central PMCID: PMC8273099.
Skolnik J, Hall D, Barkauskas DA, Moorthy G, Larson TR, Fox E, Weigel BJ, Berg SL, Reid JM. Toxicity and pharmacokinetics of actinomycin-D and vincristine in children and adolescents: Children's Oncology Group Study ADVL06B1. Cancer Chemother Pharmacol. 2021 Aug;88(2):359-365. doi: 10.1007/s00280-021-04295-1. Epub 2021 May 22. PubMed PMID: 34023919; PubMed Central PMCID: PMC8653953.
Connolly RM, Zhao F, Miller KD, Lee MJ, Piekarz RL, Smith KL, Brown-Glaberman UA, Winn JS, Faller BA, Onitilo AA, Burkard ME, Budd GT, Levine EG, Royce ME, Kaufman PA, Thomas A, Trepel JB, Wolff AC, Sparano JA. E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group. J Clin Oncol. 2021 Oct 1;39(28):3171-3181. doi: 10.1200/JCO.21.00944. Epub 2021 Aug 6. PubMed PMID: 34357781; PubMed Central PMCID: PMC8478386.
Wieduwilt MJ, Yin J, Wetzler M, Uy GL, Powell BL, Kolitz JE, Liedtke M, Stock W, Beumer JH, Mattison RJ, Storrick E, Christner SM, Lewis LD, Devine S, Stone RM, Larson RA. Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL. Blood Adv. 2021 Nov 23;5(22):4691-4700. doi: 10.1182/bloodadvances.2021004813. PubMed PMID: 34492682.
Voorhees PM, Suman VJ, Tuchman SA, Laubach JP, Hassoun H, Efebera YA, Mulkey F, Bova-Solem M, Santo K, Carlisle D, McCarthy PL, Richardson PG. A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202). Am J Hematol. 2021 Dec 1;96(12):1595-1603. doi: 10.1002/ajh.26361. Epub 2021 Oct 6. PubMed PMID: 34559902; PubMed Central PMCID: PMC8713771.